|
1
|
Patil TB, Shrikhande SV, Kanhere HA, Saoji
RR, Ramadwar MR and Shukla PJ: Solid pseudopapillary neoplasm of
the pancreas: A single institution experience of 14 cases. HPB
(Oxford). 8:148–150. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Frantz VK: Tumors of the pancreasAnonymous
Atlas of Tumor Pathology. Armed Forces Institute of Pathology;
Washington, DC: pp. 32–33. 1959
|
|
3
|
Martin RC, Klimstra DS, Brennan MF and
Conlon KC: Solid-pseudopapillary tumor of the pancreas: A surgical
enigma? Ann Surg Oncol. 9:35–40. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Reindl BA, Lynch DW and Jassim AD:
Aggressive variant of a solid pseudopapillary neoplasm: A case
report and literature review. Arch Pathol Lab Med. 138:974–978.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Cao D, Maitra A, Saavedra JA, Klimstra DS,
Adsay NV and Hruban RH: Expression of novel markers of pancreatic
ductal adenocarcinoma in pancreatic nonductal neoplasms: Additional
evidence of different genetic pathways. Mod Pathol. 18:752–761.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cavard C, Audebourg A, Letourneur F,
Audard V, Beuvon F, Cagnard N, Radenen B, Varlet P, Vacher-Lavenu
MC and Perret C: Gene expression profiling provides insights into
the pathways involved in solid pseudopapillary neoplasm of the
pancreas. J pathol. 218:201–209. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Abraham SC, Klimstra DS, Wilentz RE, Yeo
CJ, Conlon K, Brennan M, Cameron JL, Wu TT and Hruban RH:
Solid-pseudopapillary tumors of the pancreas are genetically
distinct from pancreatic ductal adenocarcinomas and almost always
harbor beta-catenin mutations. Am J Pathol. 160:1361–1369. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kobayashi T, Ozasa M, Miyashita K, Saga A,
Miwa K, Saito M, Morioka M, Takeuchi M, Takenouchi N, Yabiku T, et
al: Large solid-pseudopapillary neoplasm of the pancreas with
aberrant protein expression and mutation of β-catenin: A case
report and literature review of the distribution of β-catenin
mutation. Intern Med. 52:2051–2056. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Park M, Kim M, Hwang D, Park M, Kim WK,
Kim SK, Shin J, Park ES, Kang CM, Paik YK and Kim H:
Characterization of gene expression and activated signaling
pathways in solid-pseudopapillary neoplasm of pancreas. Mod Pathol.
27:580–593. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Giles RH, van Es JH and Clevers H: Caught
up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta.
1653:1–24. 2003.PubMed/NCBI
|
|
11
|
Kang CM, Kim HK, Kim H, Choi GH, Kim KS,
Choi JS and Lee WJ: Expression of Wnt target genes in solid
pseudopapillary tumor of the pancreas: A pilot study. Pancreas.
38:e53–59. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Aberle H, Schwartz H and Kemler R:
Cadherin-catenin complex: Protein interactions and their
implications for cadherin function. J Cell Biochem. 61:514–523.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Tang WW, Stelter AA, French S, Shen S, Qiu
S, Venegas R, Wen J, Wang HQ and Xie J: Loss of cell-adhesion
molecule complexes in solid pseudopapillary tumor of pancreas. Mod
Pathol. 20:509–513. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Park M, Kim M, Hwang D, Park M, Kim WK,
Kim SK, Shin J, Park ES, Kang CM, Paik YK and Kim H:
Characterization of gene expression and activated signaling
pathways in solid-pseudopapillary neoplasm of pancreas. Mod Pathol.
27:580–593. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Smyth GK: Linear models and empirical
bayes methods for assessing differential expression in microarray
experiments. Stat Appl Genet Mol Biol. 3:Article32004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Gautier L, Cope L, Bolstad BM and Irizarry
RA: affy-analysis of Affymetrix GeneChip data at the probe level.
Bioinformatics. 20:307–315. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Irizarry RA, Hobbs B, Collin F,
Beazer-Barclay YD, Antonellis KJ, Scherf U and Speed TP:
Exploration, normalization, and summaries of high density
oligonucleotide array probe level data. Biostatistics. 4:249–264.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ashburner M, Ball CA, Blake JA, Botstein
D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT,
et al: Gene ontology: Tool for the unification of biology. The Gene
Ontology Consortium. Nat Genet. 25:25–29. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kanehisa M and Goto S: KEGG: kyoto
encyclopedia of genes and genomes. Nucleic acids Res. 28:27–30.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
da W Huang, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009.PubMed/NCBI
|
|
21
|
Theodosiou T, Angelis L, Vakali A and
Thomopoulos GN: Gene functional annotation by statistical analysis
of biomedical articles. Int J Med Inform. 76:601–613. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen JS, Hung WS, Chan HH, Tsai SJ and Sun
HS: In silico identification of oncogenic potential of fyn-related
kinase in hepatocellular carcinoma. Bioinformatics. 29:420–427.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhao M, Sun J and Zhao Z: TSGene: A web
resource for tumor suppressor genes. Nucleic acids Res.
41:D970–D976. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Franceschini A, Szklarczyk D, Frankild S,
Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering C
and Jensen LJ: STRING v9.1: Protein-protein interaction networks,
with increased coverage and integration. Nucleic Acids Res.
41:D808–D815. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Beisser D, Klau GW, Dandekar T, Muller T
and Dittrich MT: BioNet: An R-Package for the functional analysis
of biological networks. Bioinformatics. 26:1129–1130. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Schriml LM, Arze C, Nadendla S, Chang YW,
Mazaitis M, Felix V, Feng G and Kibbe WA: Disease Ontology: A
backbone for disease semantic integration. Nucleic acids Res.
40:D940–D946. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shi C, Daniels JA and Hruban RH: Molecular
characterization of pancreatic neoplasms. Adv Anat Pathol.
15:185–195. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Huang WB, Zhou XJ, Chen JY, Zhang LH, Meng
K, Ma HH and Lu ZF: CD10-positive stromal cells in gastric
carcinoma: Correlation with invasion and metastasis. Jap J Clin
Oncol. 35:245–250. 2005. View Article : Google Scholar
|
|
29
|
Makretsov NA, Hayes M, Carter BA, Dabiri
S, Gilks CB and Huntsman DG: Stromal CD10 expression in invasive
breast carcinoma correlates with poor prognosis, estrogen receptor
negativity, and high grade. Mod Pathol. 20:84–89. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ogawa H, Iwaya K, Izumi M, Kuroda M,
Serizawa H, Koyanagi Y and Mukai K: Expression of CD10 by stromal
cells during colorectal tumor development. Hum Pathol. 33:806–811.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ikenaga N, Ohuchida K, Mizumoto K, Cui L,
Kayashima T, Morimatsu K, Moriyama T, Nakata K, Fujita H and Tanaka
M: CD10+ pancreatic stellate cells enhance the progression of
pancreatic cancer. Gastroenterology. 139:1041–1051, 1051.e1-8.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Koshiba T, Hosotani R, Wada M, Miyamoto Y,
Fujimoto K, Lee JU, Doi R, Arii S and Imamura M: Involvement of
matrix metalloproteinase-2 activity in invasion and metastasis of
pancreatic carcinoma. Cancer. 82:642–650. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Destouches D, Huet E, Sader M, Frechault
S, Carpentier G, Ayoul F, Briand JP, Menashi S and Courty J:
Multivalent pseudopeptides targeting cell surface nucleoproteins
inhibit cancer cell invasion through tissue inhibitor of
metalloproteinases 3 (TIMP-3) release. J Biol Chem.
287:43685–43693. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
El-Ghlban S, Kasai T, Shigehiro T, Yin HX,
Sekhar S, Ida M, Sanchez A, Mizutani A, Kudoh T, Murakami H and
Seno M: Chlorotoxin-Fc fusion inhibits release of MMP-2 from
pancreatic cancer cells. Biomed Res Int. 2014:1526592014.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang T, Yang J, Xu J, Li J, Cao Z, Zhou L,
You L, Shu H, Lu Z, Li H, et al: CHIP is a novel tumor suppressor
in pancreatic cancer through targeting EGFR. Oncotarget.
5:1969–1986. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tzeng CW, Frolov A, Frolova N, Jhala NC,
Howard JH, Vickers SM, Buchsbaum DJ, Heslin MJ and Arnoletti JP:
EGFR genomic gain and aberrant pathway signaling in pancreatic
cancer patients. J Surg Res. 143:20–26. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Stock AM, Hahn SA, Troost G, Niggemann B,
Zänker KS and Entschladen F: Induction of pancreatic cancer cell
migration by an autocrine epidermal growth factor receptor
activation. Exp cell Res. 326:307–314. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yarden Y and Sliwkowski MX: Untangling the
ErbB signalling network. Nat Rev Mol Cell Biol. 2:127–137. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wisdom R, Johnson RS and Moore C: c-Jun
regulates cell cycle progression and apoptosis by distinct
mechanisms. EMBO J. 18:188–197. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Peeper DS, Upton TM, Ladha MH, Neuman E,
Zalvide J, Bernards R, DeCaprio JA and Ewen ME: Ras signalling
linked to the cell-cycle machinery by the retinoblastoma protein.
Nature. 386:177–181. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Woods D, Parry D, Cherwinski H, Bosch E,
Lees E and McMahon M: Raf-induced proliferation or cell cycle
arrest is determined by the level of Raf activity with arrest
mediated by p21Cip1. Mol Cell Biol. 17:5598–5611. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Meyer N and Penn LZ: Reflecting on 25
years with MYC. Nat Rev Cancer. 8:976–990. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Li YJ, Wei ZM, Meng YX and Ji XR:
Beta-catenin up-regulates the expression of cyclinD1, c-myc and
MMP-7 in human pancreatic cancer: Relationships with carcinogenesis
and metastasis. World J Gastroenterol. 11:2117–2123. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
He C, Jiang H, Geng S, Sheng H, Shen X,
Zhang X, Zhu S, Chen X, Yang C and Gao H: Expression and prognostic
value of c-Myc and Fas (CD95/APO1) in patients with pancreatic
cancer. Int J Clin Exp Pathol. 7:742–750. 2014.PubMed/NCBI
|
|
45
|
Amati B, Alevizopoulos K and Vlach J: Myc
and the cell cycle. Front Biosci. 3:d250–d268. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Hynes NE and Lane HA: ERBB receptors and
cancer: The complexity of targeted inhibitors. Nat Rev Cancer.
5:341–354. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Olayioye MA, Neve RM, Lane HA and Hynes
NE: The ErbB signaling network: Receptor heterodimerization in
development and cancer. EMBO J. 19:3159–3167. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Dimova I, Raicheva S, Dimitrov R, Doganov
N and Toncheva D: Coexistence of copy number increases of c-Myc,
ZNF217, CCND1, ErbB1 and ErbB2 in ovarian cancers. Onkologie.
32:405–410. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Muthuswamy SK, Li D, Lelievre S, Bissell
MJ and Brugge JS: ErbB2, but not ErbB1, reinitiates proliferation
and induces luminal repopulation in epithelial acini. Nat Cell
Biol. 3:785–792. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Morgan K, Meyer C, Miller N, Sims AH,
Cagnan I, Faratian D, Harrison DJ, Millar RP and Langdon SP: GnRH
receptor activation competes at a low level with growth signaling
in stably transfected human breast cell lines. BMC Cancer.
11:4762011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Sikora SS and Vali S: Solid
pseudopapillary tumor and wnt signaling pathway Way to go!? J
Gastroenterol Hepatol. 26:215–217. 2011. View Article : Google Scholar : PubMed/NCBI
|
